Document Detail

Advances in Growth Factor Delivery for Therapeutic Angiogenesis.
MedLine Citation:
PMID:  23154615     Owner:  NLM     Status:  Publisher    
Therapeutic angiogenesis is a new revascularization strategy involving the administration of growth factors to induce new vessel formation. The biology and delivery of angiogenic growth factors involved in vessel formation have been extensively studied but success in translating the angiogenic capacity of growth factors into benefits for vascular disease patients is still limited. This could be attributed to issues related to patient selection, growth factor delivery methods or lack of vessel maturation. Comprehensive understanding of the cellular and molecular cross-talk during the different stages of vascular development is needed for the design of efficient therapeutic strategies. The presentation of angiogenic factors either in series or in parallel using a strategy that mimics physiological events, such as concentration and spatio-temporal profiles, is an immediate requirement for functional blood vessel formation. This review provides an overview of the recent delivery strategies of angiogenic factors and discusses targeting neovascular maturation as a promising approach to induce stable and functional vessels for therapeutic angiogenesis.
Somiraa S Said; J Geoffrey Pickering; Kibret Mequanint
Related Documents :
9164655 - Variants of integrin beta 4 subunit in human endometrial adenocarcinoma cells: mediator...
20080785 - Defining the role of syndecan-4 in mechanotransduction using surface-modification appro...
7781865 - Integrins and reproduction.
23327585 - Attachment of flexible heparin chains to gelatin scaffolds improves endothelial cell in...
16002135 - The effect of surface chemistry modification of titanium alloy on signalling pathways i...
12614475 - Melatonin modulates the action of near infrared radiation on cell adhesion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-15
Journal Detail:
Title:  Journal of vascular research     Volume:  50     ISSN:  1423-0135     ISO Abbreviation:  J. Vasc. Res.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9206092     Medline TA:  J Vasc Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  35-51     Citation Subset:  -    
Copyright Information:
Copyright © 2012 S. Karger AG, Basel.
Biomedical Engineering Graduate Program, The University of Western Ontario, London, Ont., Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Using alkaline-earth metal ions to tune structural variations of 1,3,5-benzenetricarboxylate coordin...
Next Document:  Maternal Serum Soluble Endoglin at 30-33 Weeks in the Prediction of Preeclampsia.